Skip to content
Clinical Trials
Our Network
Our Story
Clinical Trials
Our Network
Our Story
OnCore Login
Clinical Trials
Current Trials
Publications
Our Network
Clinical Trial Working Groups
Sponsor-Investigators
Fostering an Environment of Mentorship
Member Sites
Partners in Research
About
Our Story
Our Team
Annual Reports
Services
Biorepository & Correlative Services
Rapid Accrual
Efficient Timelines for Activation
Regulatory Compliance
Accurate & Relevant Data
News & Events
HCRN Calendar
Oncology Meetings
Make a Difference
Donate Now
Fundraising Events
Advocacy Organizations
Honor Your Hero
Careers
Contact
OnCore Login
HCRN Directory
Cholangiocarcinoma
BTCRC-GI22-564
Phase 2 Study of Gemcitabine, Cisplatin, Quemliclustat (AB680) and Zimberelimab (AB122) during First-Line Treatment of Advanced Biliary Tract Cancers: Big Ten Cancer Research Consortium BTCRC-GI22-564
Status
Cancer Types
Cholangiocarcinoma
Locations
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
,
University of Wisconsin Carbone Cancer Center
Read more
HCRN-GI19-414
Molecularly Driven, Immune-Based, Maintenance Niraparib and Dostarlimab in Advanced Stage Cholangiocarcinoma
Status
Closed
Cancer Types
Cholangiocarcinoma
Locations
Read more
Current Trials
Our Network
Our Story
X